These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24912657)

  • 1. Guest editorial: acute promyelocytic leukemia: change from "highly fatal to highly curable" leukemia.
    Komatsu N
    Int J Hematol; 2014 Jul; 100(1):16-7. PubMed ID: 24912657
    [No Abstract]   [Full Text] [Related]  

  • 2. APL, a model disease for cancer therapies?
    de Thé H; Chelbi-Alix MK
    Oncogene; 2001 Oct; 20(49):7136-9. PubMed ID: 11704841
    [No Abstract]   [Full Text] [Related]  

  • 3. All-trans retinoic acid and arsenic trioxide resistance of acute promyelocytic leukemia with the variant STAT5B-RARA fusion gene.
    Strehl S; König M; Boztug H; Cooper BW; Suzukawa K; Zhang SJ; Chen HY; Attarbaschi A; Dworzak MN
    Leukemia; 2013 Jul; 27(7):1606-10. PubMed ID: 23271512
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute promyelocytic leukemia: new issues on pathogenesis and treatment response.
    Vitoux D; Nasr R; de The H
    Int J Biochem Cell Biol; 2007; 39(6):1063-70. PubMed ID: 17468032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sweet fruit from a poisonous kiss.
    Liu D
    J Hematol Oncol; 2010 May; 3():19. PubMed ID: 20509866
    [No Abstract]   [Full Text] [Related]  

  • 6. Variant acute promyelocytic leukaemia with novel NAB2::RARA fusion shows clinical all-trans retinoic acid and arsenic trioxide sensitivity.
    Ng Liet Hing M; Ryland GL; Nguyen T; Tiong IS; Dun K; Ninkovic S; Nedumannil R; Westerman DA; Blombery PA; Chan KL; Bajel A
    Br J Haematol; 2023 Aug; 202(4):893-896. PubMed ID: 37280781
    [No Abstract]   [Full Text] [Related]  

  • 7. Arsenic: a new place?
    Vincent PC
    Pathology; 1999 May; 31(2):81-2. PubMed ID: 10399159
    [No Abstract]   [Full Text] [Related]  

  • 8. How I treat acute promyelocytic leukemia.
    Tallman MS; Altman JK
    Blood; 2009 Dec; 114(25):5126-35. PubMed ID: 19797519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication of acute promyelocytic leukemia-initiating cells by PML/RARA-targeting.
    Nasr R; de Thé H
    Int J Hematol; 2010 Jun; 91(5):742-7. PubMed ID: 20455087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide may improve the prognosis of APL with ider(17)(q10): report of a rare adult case of acute promyelocytic leukemia with ider(17)(q10)t(15;17) showing poor response to all-trans retinoic acid.
    Tong H; Li K; Mei C; Wang H; Chen Z; Jin J
    Ann Hematol; 2011 Dec; 90(12):1493-4. PubMed ID: 21431323
    [No Abstract]   [Full Text] [Related]  

  • 11. [Coagulopathy and differentiation syndrome: the main complications of the initial treatment of acute promyelocytic leukemia].
    Korístek Z; Zák P
    Vnitr Lek; 2008; 54(7-8):745-50. PubMed ID: 18780573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful unrelated bone marrow transplantation after arsenic trioxide treatment in a patient with relapsed acute promyelocytic leukemia.
    Mikoshiba M; Ohashi K; Takei N; Okuyama Y; Maeda Y; Hiruma K; Akiyama H; Fukuhara O; Takeshita A; Sakamaki H
    Int J Hematol; 2002 Jan; 75(1):104-6. PubMed ID: 11843281
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of acute promyelocytic leukemia in children: arsenic or ATRA.
    Ravindranath Y; Gregory J; Feusner J
    Leukemia; 2004 Oct; 18(10):1576-7. PubMed ID: 15356650
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeted therapy: The new lease on life for acute promyelocytic leukemia, and beyond.
    Chen SJ; Zhou GB
    IUBMB Life; 2012 Aug; 64(8):671-5. PubMed ID: 22714999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PML-RARalpha inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia.
    Ohnishi K
    Int J Clin Oncol; 2007 Oct; 12(5):313-7. PubMed ID: 17929112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of the antileukemia activities of retinoid and arsenic.
    Nitto T; Sawaki K
    J Pharmacol Sci; 2014; 126(3):179-85. PubMed ID: 25319615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagic degradation of an oncoprotein.
    Bøe SO; Simonsen A
    Autophagy; 2010 Oct; 6(7):964-5. PubMed ID: 20724820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hot on the TRAIL of acute promyelocytic leukemia.
    Zelent A
    Nat Med; 2001 Jun; 7(6):662-4. PubMed ID: 11385499
    [No Abstract]   [Full Text] [Related]  

  • 19. ATRA plus arsenic gets another "A" in APL.
    Park JH
    Blood; 2012 Aug; 120(8):1535-6. PubMed ID: 22918418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for the treatment of acute promyelocytic leukemia.
    Frankfurt O; Tallman MS
    J Natl Compr Canc Netw; 2006 Jan; 4(1):37-50. PubMed ID: 16403403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.